Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Dietary Supplement Reps Ask FDA For Clarity Across The Board On NDIs

This article was originally published in The Tan Sheet

Executive Summary

FDA should focus the 75-day premarket notification process specifically on ingredients, not finished products, industry stakeholders asserted at the agency's public meeting on new dietary ingredient (NDI) submissions Nov. 15
Advertisement

Related Content

Attorneys See FDA Rulemaking By Guidance In NDI Notification Draft
Attorneys See FDA Rulemaking By Guidance In NDI Notification Draft
Attorneys See FDA Rulemaking By Guidance In NDI Notification Draft
Attorneys See FDA Rulemaking By Guidance In NDI Notification Draft
FDA Requiring GRAS-Level Safety Standards For NDI Submissions, Experts Say
FDA Requiring GRAS-Level Safety Standards For NDI Submissions, Experts Say
Supplement GMPs, NDI Guidance Should Top CFSAN 2007 Priority List – CRN
Qualified Health Claim Draft Guidance Should Top CFSAN ‘06 Priorities – CHPA
Changes To “Old” Dietary Ingredients Do Not Make Them “New” – CRN, NNFA
CFSAN 2005 Priorities: “Per Day” Labeling, NDI Revised Definitions

Topics

Advertisement
UsernamePublicRestriction

Register

PS097535

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel